ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,427, issued on Oct. 21, was assigned to ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) (Leiden, Netherlands).
"Binding proteins specific for HA-1 H and uses thereof" was invented by Mirjam H.M. Heemskerk (Leiden, Netherlands) and J.H. Frederik Falkenburg (Leiden, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "Novel nucleic acid compositions, vectors, modified cells and pharmaceutical compositions are provided that are useful for treating or preventing a relapse of a haematological malignancy after allogeneic stem cell transplantation (allo-SCT) in a HLA-A*0201 positive human subject. Corresponding methods and uses are also provided."
The ...